Drawing for ESSEX

USPTO serial 79257680

ESSEX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LEIPZIG, MARC J
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ESSEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Prakash NAMA

121 Moore St.Princeton, NJ 08540UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicines for human purposes, namely, medicinal drinks, herbs, teas and medicines for treating asthma; chemico-pharmaceutical preparations for treating asthma and high blood pressure; vaccines; biological preparations for medical purposes, namely, for treating cancer and hair loss; chemical preparations for pharmaceutical purposes for treating asthma and high blood pressure; mouthwashes for medical purposes; injectable pharmaceuticals for treating asthma and high blood pressure; medicinal preparations for the mouth in the form of tablets; medicinal preparations in the form of aqueous solution for treating asthma and high blood pressure; crude drug in the nature of pharmaceutical preparations for use in the treatment of asthma and high blood pressure; medicinal herbs; biochemical drug for treating asthma and high blood pressure; inhaled pharmaceutical preparations for the treatment of respiratory diseases and respiratory disorders; drugs for the treatment of respiratory diseases; collyrium; suppositories; pharmaceutical preparation for the treatment of dermatosis; medical plaster; diagnostic preparations for medical or veterinary use; diagnostic radiopharmaceutical preparations; disinfectants; dietetic foods adapted for medical purposes; dietetic foods and beverages adapted for medical use; nutritional supplements; mineral food supplements; protein dietary supplements; lecithin dietary supplements; dressings, medical; surgical dressings; surgical glues; dental masticsACTIVE—
044Medical clinic services; hospital services; health care; pharmaceutical advice; plastic surgery; telemedicine services; preparation of prescriptions by pharmacists; health counseling; human tissue bank services; dermatology services; convalescent home services; beauty salon services; opticians' servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 13, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 27, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 8, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 8, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 24, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 7, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 7, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 8, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 8, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 26, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 26, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 26, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 4, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 4, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 4, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 22, 2019RFNTREFUSAL PROCESSED BY IB—
Jun 4, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 4, 2019RFRRREFUSAL PROCESSED BY MPU—
May 14, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 13, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
May 6, 2019DOCKASSIGNED TO EXAMINER—
May 6, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 2, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance